MAP2 and Parkinson disease: On the other hand, the neuroprotective activity of GSE against the Rotenone-induced PD model, as schematically represented in Scheme S1, was also demonstrated by the restoration of neurite loss from TH+/MAP2+ neurons and mitochondrial respiration in dopaminergic cells.